Similarly, our study finds that SNHG20 is highly expressed in glioma tissues and cells, and knockdown of SNHG20 reduces VM of glioma by reducing the expression of VM-related molecular MMP1, MMP9, VE-Cadherin. This evidence concerns the gene MMP9 and central nervous system cancer.